MDTS

MDTS detects de novo copy number deletions from capture-based targeted sequencing of parent–offspring trios.

Key Features:

• High sensitivity and precision: Demonstrates sensitivity (recall) comparable to existing methods while substantially reducing false positive rates, yielding higher positive predictive value (precision).
• Scalability: Processes large capture-based targeted sequencing datasets for high-throughput studies without loss of performance.
• Minimum-distance calculation framework: Employs minimum distance calculations tailored for targeted sequencing to discriminate true de novo deletions from artifacts and non-specific CNV calls.

Scientific Applications:

• De novo deletion detection in trios: Identifies de novo copy number deletions in parent–offspring trios that are implicated in genetic diseases.
• Genetic research and precision medicine: Supports studies of hereditary conditions and contributes to analyses relevant to personalized medicine by accurately pinpointing de novo CN deletions.

Methodology:

MDTS applies minimum distance calculations tailored for capture-based targeted sequencing and prioritizes precision to minimize false positives while maintaining high sensitivity.